科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/21 | 3,796 | 3,829 | 3,775 | 3,778 | -21 | -0.6% | 225,500 |
| 2024/06/20 | 3,772 | 3,810 | 3,765 | 3,799 | +5 | +0.1% | 158,300 |
| 2024/06/19 | 3,712 | 3,838 | 3,712 | 3,794 | +74 | +2% | 179,000 |
| 2024/06/18 | 3,754 | 3,764 | 3,716 | 3,720 | -36 | -1% | 82,300 |
| 2024/06/17 | 3,767 | 3,780 | 3,715 | 3,756 | -9 | -0.2% | 129,500 |
| 2024/06/14 | 3,720 | 3,769 | 3,716 | 3,765 | +32 | +0.9% | 138,600 |
| 2024/06/13 | 3,784 | 3,784 | 3,725 | 3,733 | -57 | -1.5% | 96,600 |
| 2024/06/12 | 3,823 | 3,826 | 3,790 | 3,790 | -1 | ±0% | 102,700 |
| 2024/06/11 | 3,810 | 3,820 | 3,791 | 3,791 | -15 | -0.4% | 73,400 |
| 2024/06/10 | 3,795 | 3,823 | 3,770 | 3,806 | -17 | -0.4% | 119,000 |
| 2024/06/07 | 3,824 | 3,842 | 3,806 | 3,823 | -20 | -0.5% | 171,200 |
| 2024/06/06 | 3,925 | 3,985 | 3,821 | 3,843 | -12 | -0.3% | 363,000 |
| 2024/06/05 | 3,722 | 3,855 | 3,693 | 3,855 | +94 | +2.5% | 455,000 |
| 2024/06/04 | 3,788 | 3,827 | 3,636 | 3,761 | -27 | -0.7% | 555,500 |
| 2024/06/03 | 3,667 | 3,874 | 3,646 | 3,788 | +213 | +6% | 662,700 |
| 2024/05/31 | 3,662 | 3,674 | 3,534 | 3,575 | -91 | -2.5% | 401,200 |
| 2024/05/30 | 3,590 | 3,680 | 3,570 | 3,666 | +47 | +1.3% | 385,700 |
| 2024/05/29 | 3,584 | 3,645 | 3,540 | 3,619 | +175 | +5.1% | 427,500 |
| 2024/05/28 | 3,460 | 3,463 | 3,444 | 3,444 | -24 | -0.7% | 87,800 |
| 2024/05/27 | 3,452 | 3,468 | 3,441 | 3,468 | +6 | +0.2% | 85,300 |
| 2024/05/24 | 3,438 | 3,462 | 3,431 | 3,462 | +24 | +0.7% | 73,100 |
| 2024/05/23 | 3,415 | 3,450 | 3,406 | 3,438 | +30 | +0.9% | 70,800 |
| 2024/05/22 | 3,427 | 3,431 | 3,407 | 3,408 | -28 | -0.8% | 89,000 |
| 2024/05/21 | 3,439 | 3,481 | 3,436 | 3,436 | -4 | -0.1% | 127,000 |
| 2024/05/20 | 3,439 | 3,455 | 3,416 | 3,440 | -11 | -0.3% | 102,000 |
| 2024/05/17 | 3,426 | 3,455 | 3,416 | 3,451 | +8 | +0.2% | 115,300 |
| 2024/05/16 | 3,383 | 3,443 | 3,378 | 3,443 | +61 | +1.8% | 119,000 |
| 2024/05/15 | 3,473 | 3,473 | 3,378 | 3,382 | -101 | -2.9% | 249,800 |
| 2024/05/14 | 3,535 | 3,560 | 3,449 | 3,483 | -65 | -1.8% | 358,200 |
| 2024/05/13 | 3,520 | 3,560 | 3,506 | 3,548 | +28 | +0.8% | 179,000 |
| 2024/05/10 | 3,497 | 3,520 | 3,478 | 3,520 | +37 | +1.1% | 170,600 |
| 2024/05/09 | 3,478 | 3,499 | 3,464 | 3,483 | +4 | +0.1% | 177,900 |
| 2024/05/08 | 3,466 | 3,487 | 3,456 | 3,479 | +11 | +0.3% | 113,600 |
| 2024/05/07 | 3,470 | 3,481 | 3,456 | 3,468 | -10 | -0.3% | 128,300 |
| 2024/05/02 | 3,481 | 3,485 | 3,463 | 3,478 | +1 | ±0% | 108,100 |
| 2024/05/01 | 3,425 | 3,488 | 3,409 | 3,477 | +52 | +1.5% | 128,400 |
| 2024/04/30 | 3,425 | 3,442 | 3,399 | 3,425 | +18 | +0.5% | 202,200 |
| 2024/04/26 | 3,387 | 3,416 | 3,367 | 3,407 | +18 | +0.5% | 132,500 |
| 2024/04/25 | 3,411 | 3,416 | 3,389 | 3,389 | -29 | -0.8% | 120,000 |
| 2024/04/24 | 3,435 | 3,446 | 3,414 | 3,418 | -21 | -0.6% | 149,100 |
| 2024/04/23 | 3,456 | 3,458 | 3,421 | 3,439 | -19 | -0.5% | 94,300 |
| 2024/04/22 | 3,436 | 3,464 | 3,426 | 3,458 | +44 | +1.3% | 125,500 |
| 2024/04/19 | 3,423 | 3,423 | 3,394 | 3,414 | -9 | -0.3% | 90,200 |
| 2024/04/18 | 3,389 | 3,433 | 3,389 | 3,423 | +35 | +1% | 69,700 |
| 2024/04/17 | 3,417 | 3,417 | 3,375 | 3,388 | -36 | -1.1% | 99,400 |
| 2024/04/16 | 3,416 | 3,436 | 3,412 | 3,424 | -4 | -0.1% | 98,000 |
| 2024/04/15 | 3,423 | 3,436 | 3,416 | 3,428 | -10 | -0.3% | 71,100 |
| 2024/04/12 | 3,420 | 3,438 | 3,415 | 3,438 | +20 | +0.6% | 73,200 |
| 2024/04/11 | 3,418 | 3,430 | 3,403 | 3,418 | -7 | -0.2% | 87,200 |
| 2024/04/10 | 3,426 | 3,446 | 3,425 | 3,425 | +5 | +0.1% | 82,400 |
251～
300
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 379,100円 | -6.4% | -71.8% | 5.01% | 42.34倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| サンバイオ | 233,200円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ジーエヌアイ | 330,000円 | +21.7% | +999.9% | 0.00% | 13.83倍 | 4.76倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 299,700円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
